The effects of exenatide and exenatide + exendin 9 on endothelial function in patients with type 2 diabetes mellitus or impaired glucose tolerance under fasting conditions

Trial Profile

The effects of exenatide and exenatide + exendin 9 on endothelial function in patients with type 2 diabetes mellitus or impaired glucose tolerance under fasting conditions

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Jul 2013

At a glance

  • Drugs Exenatide (Primary) ; Exendin 9
  • Indications Glucose intolerance; Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 09 Jul 2013 New trial record
    • 25 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top